HOME >> MEDICINE >> NEWS
28-site trial studying Chinese herb as Alzheimer's treatment

Washington, DC Researchers from Georgetown University Medical Center's Memory Disorders Program are directing the first U.S. study to determine whether huperzine A, derived from the Chinese club moss plant Huperzia serrata, improves cognitive function in people with Alzheimer's disease (AD). The study, which is recruiting participants at 28 sites across the country, is jointly funded by the National Institutes of Health and Neuro-Hitech Pharmaceuticals, Inc.

Huperzine A, a naturally occurring cholinesterase inhibitor, has been used in Chinese folk medicine for the treatment of fevers and inflammation. Although also commonly used in China to treat Alzheimer's, there have been no controlled clinical trials assessing its toxicity and efficacy outside of China. Chinese studies have suggested that huperzine A is well tolerated and effective.

Paul Aisen, M.D., professor of neurology and leader of the new multi-site study, says huperzine A shows great promise as a treatment for AD. "Based on studies in China, huperzine A may be more effective and better tolerated than currently prescribed drugs for Alzheimer's Disease. In addition, laboratory studies suggest that huperzine may have unique effects that could slow down the progression of the disease."

Huperzine A is currently available in the U.S. and is used by some American physicians to treat A.D. The herb is classified as a nutriceutical by the U.S. Food and Drug Administration, does not require a prescription and is contained in some products sold in health food stores and pharmacies.

The huperzine A study will enroll approximately 150 participants, age 55 or older, with mild to moderate A.D. The trial focuses on individuals who have not found currently approved cholinesterase inhibitors (including Aricept, Reminyl, Exelon or Cognex), effective or tolerable. Cholinesterase inhibitors have been proven to relieve memory impairment and other symptoms associated with A.D.

As
'"/>

Contact: Liz McDonald
eem6@georgetown.edu
202-687-5100
Georgetown University Medical Center
26-Apr-2006


Page: 1 2

Related medicine news :

1. New contracts support clinical trials on antibiotic-resistant, community-acquired staph infections
2. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
3. Helicopter flight trials for EGNOS
4. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
5. GSK announces launch of largest ever Phase III trial in lung cancer treatment
6. Bias in statin trials, failure to control malaria, and more
7. International journal group updates guidelines on registration of clinical trials
8. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
9. Childrens Hospital and Pitt lead national trial of hypothermia to treat pediatric brain injury
10. Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
11. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... ... September 22, 2018 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... its 12th annual Lymphoma Research Ride, a cycling event held each year during ...
(Date:9/15/2018)... ... September 14, 2018 , ... Last night, Congressional leadership ... appropriations for Labor, Health and Human Services and Education (LHHS) and Defense. Specifically, ... (TPP) Program, and $286.5 million for the Title X Family Planning Program for ...
(Date:9/13/2018)... ... September 13, 2018 , ... Pulsara is honored to be represented by its ... on September 19-22 in Chicago. Dr. Woodson, ER Physician and Founder/CEO of Pulsara, ... titled, “Your Clinical Communication & Collaboration (CC&C) is Not Enough: Why You Need a ...
(Date:9/12/2018)... ... , ... Definitive Healthcare , the leading provider of data, intelligence, and ... Dana-Farber Cancer Institute and the Jimmy Fund. , “It’s a really fun day ... we have such wonderful sponsors and volunteers. The growth we’ve seen over past two ...
(Date:9/7/2018)... ... 2018 , ... Modere, a healthy, safe and clean-lifestyle brand ... that its Chief Executive Officer, Asma Ishaq, has been awarded the 2018 Rice ... award on Friday, September 7, at the Rice Business Alumni Awards banquet dinner. ...
Breaking Medicine News(10 mins):
(Date:9/1/2018)... (PRWEB) , ... August 31, 2018 , ... Precision ... to their practice with offices in Irving and Southlake. Fellowship trained in Spine ... Pak, Dr. Byung Lee, Dr. John Milani, Dr. Jaytinder Sandhu, and Dr. Tariq Hendawi ...
(Date:9/1/2018)... , ... September 01, 2018 , ... Two Frogs Healing ... disease, will be hosting the Getting Rid of Lyme Disease Issues with Liposomes Evening ... Center Inc. (FITCI) , Lyme Disease is the number one vector borne illness in ...
(Date:9/1/2018)... ... September 01, 2018 , ... The ... focuses on the company’s continued efforts to “Create a Better Future” through a ... preservation of natural resources. , “2017 was a positive year for Shaw, ...
Breaking Medicine Technology:
Cached News: